It is a women’s health care biotech spec with a promising pipeline. Jim Cramer learns more about its latest formulation that could be a game changer for many …
source CNBC
TherapeuticsMD Chairman & CEO: Redefining Women’s Health | Mad Money | CNBC
previous post